Surmodics | SRDX - 当期純利益





当期純利益 変化する 日付
Abbott USD 1.78B 132M 2025-12
Align Technology USD 135.76M 79.01M 2025-12
Anika Therapeutics USD -4.87M 16.99M 2025-03
Arrowhead Research USD 30.81M 54.56M 2025-12
Artivion USD -2.29M 167K 2024-09
Baxter International USD -1.13B 1.08B 2025-12
Boston Scientific USD 672M 83M 2025-12
EDAP TMS EUR -5.01M 586K 2025-09
Edwards Lifesciences USD 91.2M 199.9M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Heron Therapeutics USD -4.85M 4.39M 2024-09
J&J USD 5.12B 36M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Mesa Laboratories USD -1.68M 5.1M 2024-12
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Option Care Health USD 58.5M 6.69M 2025-12
Stryker USD 849M 10M 2025-12
Surmodics USD -11.54M 3.99M 2024-09
Trinity Biotech USD -5.14M 11.82M 2025-09